Dual blockade of the EGFR and COX-2 pathways: A phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer

Lignende værker

• Statistical methods for assays with limits of detection: Serum bile acid as a differentiator between patients with normal colons, adenomas, and colorectal cancer
  af: LaFleur, Bonnie, et al.
  Udgivet: (2011)
• A Phase I Study of Cetuximab in Combination With Gemcitabine and Radiation for Locally Advanced Pancreatic Cancer
  af: Chakravarthy, A. Bapsi, et al.
  Udgivet: (2012)
• Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer
  af: Allison S. Cohen, et al.
  Udgivet: (2020-10-01)
• Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer
  af: Cohen, Allison S., et al.
  Udgivet: (2020)
• Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer
  af: Manning, H. Charles, et al.
  Udgivet: (2008)